It is worth noting, however, that these clinical trials did not assess the impact of weight loss, including concomitant loss of lean body mass, on individuals physical function, the ultimate measure of patient-relevant outcomes
Scand J Clin Lab Invest 28:91100 Gooding KM, Lienczewski C, Papale M, Koivuviita N, Maziarz M, Dutius Andersson A-M, Sharma K, Pontrelli P, Garcia Hernandez A, Bailey J, Tobin K, Saunavaara V, Zetterqvist A, Shelley D, Teh I, Ball C, Puppala S, Ibberson M, Karihaloo A, Metsrinne K, Banks R, Gilmour PS, Mansfield M, Gilchrist M, de Zeeuw D, Heerspink HJL, Nuutila P, Kretzler M, Wellberry-Smith M, Gesualdo L, Andress D, Grenier N, Shore AC, Gomez MF, Sourbron S (2020) Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
B12 shots can range from $25 to $150 a pop
Critically, subsequent metagenomic analysis revealed that LEO (60 mg/kg) effectively reversed diabetes-associated dysbiosis, evidenced by a marked increase in -diversity (Shannon index), elevated relative abundance of Firmicutes, and specific enrichment of butyrate-producing genera such as Alistipes (Figures 3BE)
This initiative has the potential to make a lasting impact in our communities by providing more reliable, consistent access to these life-changing medications for the millions of Americans who want a better, more affordable way to take care of their health." According to the World Health Organization (WHO), around 70% of American adults have obesity or are overweight and at least 2.8 million people die each year due to being overweight or having obesity